<div id="readability-page-1"><p>Park Place Capital Corp trimmed its position in  UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 45.9% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor  owned 3,152 shares of the healthcare conglomerate's stock after selling 2,672 shares during the period. Park Place Capital Corp's holdings in UnitedHealth Group were worth $1,028,000 at the end of the most recent reporting period.</p><div><p><span></span><span>Get <strong>UnitedHealth Group</strong> alerts:</span></p></div><ul><li>More Than a Rebound: UnitedHealth Is Back in the Game</li></ul><p>A number of other hedge funds have also bought and sold shares of the company. Citizens National Bank Trust Department boosted its stake in  UnitedHealth Group by 1.0% in the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock valued at $9,368,000 after acquiring an additional 170 shares during the period.  Fort Washington Investment Advisors Inc. OH raised its holdings in shares of  UnitedHealth Group by 0.3% during the first quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock valued at $277,641,000 after buying an additional 1,465 shares during the last quarter.  Caitlin John LLC raised its holdings in shares of  UnitedHealth Group by 14.8% during the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate's stock valued at $451,000 after buying an additional 111 shares during the last quarter.  Triumph Capital Management bought a new stake in shares of  UnitedHealth Group during the second quarter valued at approximately $1,324,000.  Finally, Wealth Effects LLC raised its holdings in shares of  UnitedHealth Group by 14.4% during the second quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate's stock valued at $1,463,000 after buying an additional 591 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds. </p><h2>UnitedHealth Group Trading Up 0.2%</h2><p>NYSE UNH opened at $344.61 on Tuesday. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market cap of $312.10 billion, a price-to-earnings ratio of 14.93, a PEG ratio of 2.24 and a beta of 0.45. The firm's 50 day moving average price is $302.45 and its two-hundred day moving average price is $357.73. </p><ul><li>As the Market Rotates, This Healthcare ETF Is Leading the Way</li></ul><p>UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. During the same quarter in the previous year, the firm posted $6.80 earnings per share. The company's revenue for the quarter was up 12.9% on a year-over-year basis.  UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities analysts anticipate that  UnitedHealth Group Incorporated will post 29.54 EPS for the current year. </p><h2>UnitedHealth Group Announces Dividend</h2><p>The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.6%. The ex-dividend date was Monday, September 15th. UnitedHealth Group's payout ratio is presently 38.30%. </p><h2>Wall Street Analysts Forecast Growth</h2><ul><li>Top 5 ETFs and Stocks to Watch as the Fed Eyes Rate Cuts</li></ul><p>Several equities research analysts recently commented on the company. Barclays boosted their target price on UnitedHealth Group from $337.00 to $352.00 and gave the stock an &#34;overweight&#34; rating in a report on Thursday, September 4th. Bank of America boosted their target price on UnitedHealth Group from $290.00 to $325.00 and gave the stock a &#34;neutral&#34; rating in a report on Monday, August 18th. UBS Group  reissued a &#34;buy&#34; rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Cantor Fitzgerald  reissued an &#34;overweight&#34; rating and set a $440.00 target price on shares of UnitedHealth Group in a report on Tuesday, August 26th. Finally, JPMorgan Chase &amp; Co. dropped their target price on UnitedHealth Group from $418.00 to $310.00 and set an &#34;overweight&#34; rating on the stock in a report on Wednesday, August 6th. Sixteen investment analysts have rated the stock with a Buy rating, six have issued  a Hold rating and three have issued  a Sell rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of &#34;Moderate Buy&#34; and an average price target of $358.95.</p><p><b>Check Out Our Latest Report on UnitedHealth Group</b></p><h2>UnitedHealth Group Company Profile</h2> (Free Report)<p>UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than UnitedHealth Group</li><li>About the Markup Calculator</li><li>Tesla Earnings Loom: Bulls Eye $600, Bears Warn of $300</li><li>3 Best Fintech Stocks for a Portfolio Boost</li><li>Cathie Wood Buys Alibaba and Baidu: Momentum or More Value Ahead?</li><li>What is a penny stock? A comprehensive guide</li><li>This ETF Weeds Out Small-Cap Underperformers</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in UnitedHealth Group Right Now?</h2><p>Before you consider UnitedHealth Group, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.</p><p>While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Park Place Capital Corp reduced its stake in UnitedHealth Group (NYSE:UNH) by 45.9% in Q2, now holding 3,152 shares valued at $1,028,000. Other investors, including Citizens National Bank and Fort Washington Investment Advisors, also adjusted their positions. UnitedHealth's stock opened at $344.61, with a market cap of $312.10 billion. The company reported Q2 earnings of $4.08 per share, missing estimates, and announced a quarterly dividend of $2.21 per share. Analysts have mixed ratings, with target prices ranging from $290 to $440.</p>

UnitedHealth Group Incorporated $UNH Shares Sold by Park Place Capital Corp